Jump Financial’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,734
| Closed | -$40K | – | 2094 |
|
|
2024
Q3 | $40K | Sell |
10,734
-1,456
| -12% | -$5.43K | ﹤0.01% | 1558 |
|
|
2024
Q2 | $68.3K | Sell |
12,190
-8,333
| -41% | -$46.7K | ﹤0.01% | 1665 |
|
|
2024
Q1 | $108K | Sell |
20,523
-18,377
| -47% | -$96.3K | ﹤0.01% | 1778 |
|
|
2023
Q4 | $203K | Buy |
38,900
+24,600
| +172% | +$129K | 0.01% | 1547 |
|
|
2023
Q3 | $226K | Sell |
14,300
-1,100
| -7% | -$17.3K | 0.01% | 1449 |
|
|
2023
Q2 | $299K | Sell |
15,400
-10,051
| -39% | -$195K | 0.01% | 1306 |
|
|
2023
Q1 | $722K | Buy |
25,451
+18,187
| +250% | +$516K | 0.03% | 738 |
|
|
2022
Q4 | $212K | Buy |
+7,264
| New | +$212K | 0.01% | 1255 |
|
|
2022
Q1 | – | Sell |
-4,700
| Closed | -$239K | – | 1993 |
|
|
2021
Q4 | $239K | Buy |
+4,700
| New | +$239K | 0.02% | 1017 |
|
|
2021
Q3 | – | Sell |
-6,600
| Closed | -$282K | – | 1589 |
|
|
2021
Q2 | $282K | Buy |
6,600
+1,100
| +20% | +$47K | 0.03% | 694 |
|
|
2021
Q1 | $230K | Buy |
+5,500
| New | +$230K | 0.02% | 716 |
|